PT  - JOURNAL ARTICLE
AU  - Jiang, John (Xuefeng)
AU  - Wang, Maobin
TI  - Local public health officials and COVID-19: Evidence from China
AID  - 10.1101/2020.07.18.20156828
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.18.20156828
4099  - http://medrxiv.org/content/early/2020/07/25/2020.07.18.20156828.short
4100  - http://medrxiv.org/content/early/2020/07/25/2020.07.18.20156828.full
AB  - Understanding what contributes to the slowing down of COVID-19 in China is essential for other governments to better deal with the pandemic. Similar to their counterparts in the U.S. and the U.K., local public health authorities in China are responsible for monitoring infectious diseases and organizing the responses to public health emergencies. However they are not typically viewed as essential as China policymakers focus on economic growth. Only 38% of the heads of the public health departments of Chinese cities have a medical background. We find that cities with medical professionals as the head of public health departments had lower infection rates and death rates from COVID-19. The results were significant only at the start of the outbreak. Our results suggest to better combat a pandemic, local public health authorities should be led by competent people who have a medical background.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Public available data. Exampt from IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are from public sources